Plessers L, Bosmans E, Cox A, op de Beeck L, Vandepitte J, VanVuchelen J, Raus J
Limburgs Universitair Centrum, Diepenbeek, Belgium.
Anticancer Res. 1990 Jan-Feb;10(1):271-7.
Mouse monoclonal antibodies (Mabs) against the human breast cancer cell line MCF-7 were obtained by fusing spleen cells from immunized mice with SP2/0 myeloma cells. The Mabs obtained show a high degree of specificity for epithelial cells. They react in a heterogeneous way with neoplastic and non-neoplastic tissues. Mabs 5D10, 2B4, and 3B7 recognize the same antigen (MW 80,000-90,000) in fresh tissue and in paraffin embedded sections. Mab 11F9 recognizes another antigen which can only be detected in unfixed tissue and not in paraffin sections. A preliminary study suggests a glycolipid nature of all recognized antigens. At least one of the monoclonal antibodies (5D10) developed can be used in an in vitro and in vivo model for the study of the invasiveness of MCF-7 cells.
通过将免疫小鼠的脾细胞与SP2/0骨髓瘤细胞融合,获得了针对人乳腺癌细胞系MCF-7的小鼠单克隆抗体(Mabs)。所获得的单克隆抗体对上皮细胞具有高度特异性。它们与肿瘤组织和非肿瘤组织的反应方式各异。单克隆抗体5D10、2B4和3B7在新鲜组织和石蜡包埋切片中识别相同抗原(分子量80,000 - 90,000)。单克隆抗体11F9识别另一种仅在未固定组织中可检测到而在石蜡切片中无法检测到的抗原。初步研究表明所有识别的抗原具有糖脂性质。所开发的单克隆抗体中至少有一种(5D10)可用于体外和体内模型,以研究MCF-7细胞的侵袭性。